Long-term effectiveness of acetazolamide on permanent weakness in hyperkalemic periodic paralysis-Reference-Cited by-同舟云学术

Long-term effectiveness of acetazolamide on permanent weakness in hyperkalemic periodic paralysis

Published:2013-05 Issue:5 Volume:23 Page:445-449
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Dejthevaporn Charungthai,Papsing Chutima,Phakdeekitcharoen Bunyong,Jaovisidha Suphaneewan,Phudhichareonrat Suchart,Witoonpanich Rawiphan,Pulkes Teeratorn

Publisher

Elsevier BV

Subject

Genetics (clinical),Neurology (clinical),Neurology,Pediatrics, Perinatology and Child Health

Reference21 articles.

1. Identification of a mutation in the gene causing hyperkalemic periodic paralysis;Ptacek;Cell,1991

2. Correlating phenotype and genotype in the periodic paralyses;Miller;Neurology,2004

3. K+-dependent paradoxical membrane depolarization and Na+ overload, major and reversible contributors to weakness by ion channel leaks;Jurkat-Rott;Proc Natl Acad Sci USA,2009

4. Permanent myopathy caused by mutation of SCN4A Metl592Val: observation on myogenesis in vitro and on effect of basic fibroblast growth factor on the muscle;Feng;Neurosci Bull,2009

5. Improvement of muscle strength in familial hypokalaemic periodic paralysis with acetazolamide;Links;J Neurol Neurosurg Psychiatry,1988

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Muscle MRI in periodic paralysis shows myopathy is common and correlates with intramuscular fat accumulation;Muscle & Nerve;2023-07-28

2. The Neurological Spectrum for Acetazolamide Pharmacotherapy: from Basic Science to Clinical Applications;SN Comprehensive Clinical Medicine;2021-11-08

3. Clinical and genetic spectrum of a Chinese cohort with SCN4A gene mutations;Neuromuscular Disorders;2021-09

4. Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders;Experimental Neurology;2021-08

5. Hyperkalemic periodic paralysis aggravated by voltage - gate sodium channel blocker antiepileptic drug?;Medical Hypotheses;2020-06